Overview
Drug-induced diabetes mellitus refers to the development of hyperglycemia or diabetes mellitus as a direct consequence of certain medications. This can manifest as new-onset diabetes or worsening of pre-existing glycemic control.Diagnosis
No specific diagnostic criteria for drug-induced diabetes are provided in the abstracts.
Monitoring of blood glucose levels is implied in the context of managing drug side effects 1.Management
Metformin may be used to attenuate weight gain associated with antipsychotic medications 1.
Metformin's effectiveness in reducing weight gain and body mass index has been demonstrated in patients receiving antipsychotics 1.
The effects of metformin in this context can be maintained for 12 to 24 weeks 1.
The optimal dosage and duration of metformin for prevention and treatment of antipsychotic-induced weight gain require further large-scale research 1.
The pharmacokinetic profiles of tuberculosis drugs may be influenced by the presence of diabetes mellitus, which could guide management 2.Special Populations
The abstracts do not specifically address drug-induced diabetes in pregnancy, pediatrics, or the elderly.
The interaction between tuberculosis and diabetes mellitus is noted, impacting treatment outcomes and drug pharmacokinetics 2.Key Recommendations
Metformin may be considered to attenuate weight gain in patients receiving antipsychotics 1. (Evidence: Strong)
Further large-scale research is needed to validate findings on the optimal dosage and duration of metformin for antipsychotic-induced weight gain 1. (Evidence: Moderate)
The pharmacokinetic impact of diabetes mellitus on tuberculosis drugs should be considered for guiding management in co-infected patients 2. (Evidence: Moderate)References
1 Peng TR, Chen JA, Lee JA, Hsing CP, Lee MC, Chen SM. The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis. Schizophrenia bulletin 2025. link
2 Cevik M, Sturdy A, Maraolo AE, Dekkers BGJ, Akkerman OW, Gillespie SH et al.. A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2024. link